Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physioneal 35 vs Physioneal 40 crossover study in pediatric chronic peritoneal dialysis
2005-005434-12Phase 4Terminated
- Sponsor
- Universitätsklinikum Erlangen
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Physioneal in end-stage kidney disease (ESKD) and chronic kidney disease (CKD) (2 arms), sponsored by Universitätsklinikum Erlangen. Primary endpoint: Protein metabolism. Started May 2008; status: terminated.
02
Drugs
Physioneal
03
Conditions
end-stage kidney disease (ESKD)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-005434-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005434-12.